Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Synapse Medicine

Explore full profile

Artificial intelligence platform to manage drugs prescription

Bordeaux, FranceFounded 2017Biotech & Life Sciences
Valuation $100–250M Last recorded · 2022
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Synapse Medicine and the history behind them.

About Synapse Medicine

Synapse Medicine is a health technology company that provides AI-powered solutions to optimize drug regimens and enhance patient safety. The company serves healthcare providers and their patients, operating in the digital health market. Synapse Medicine's core product is a suite of pre-built, plug-and-play prescription assistance APIs and components that improve prescribing accuracy and safety. The business model is B2B (business-to-business), where healthcare organizations integrate Synapse Medicine's solutions into their platforms to streamline medication management and ensure safer patient care. Revenue is generated through subscription fees and licensing of their APIs and components. Synapse Medicine's innovative solutions, such as Synapse Copilot and Synapse Medication Shield, facilitate the management of adverse event reports and provide healthcare professionals with intelligent tools for better decision-making.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2017
Headquarters
Bordeaux, France
Employees
85
Open positions
4
Dealroom signal
73.6/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology, Health Platform
Sector
Biotech & Life Sciences, Medication Adherence, Biotechnology, Medical Imaging, Core AI, Spinout, Tech for Hospitals and Clinics
Technology
Artificial Intelligence, Machine Learning
Business model
SaaS
Client focus
b2b

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Mar 2022 $28M $112M XAnge · BNP Paribas Développement · MACSF · Korelya Capital ↗
SERIES A✓Equity / VC Jul 2020 $8M $32M Bpifrance · BNP Paribas · MACSF · XAnge ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Synapse Medicine website traffic

Latest recorded traffic for Synapse Medicine is 27K monthly website visits, up 28.6% over the last three months. Synapse Medicine's team grew 1.2% over the past year.

Latest monthly visits27K 3-month web change+28.6% 1-year team growth+1.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Series A6 investors entered at this stage

  • MACSF
  • Bpifrance
  • BNP Paribas
  • Nicolas Dessaigne
  • Korelya Capital
  • BNP Paribas Développement

Other known investors5 additional known investors

  • INSERM
  • University Hospital of Bordeaux
  • University of Bordeaux
  • Kima Ventures
  • Siparex
Team profiled 17 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇫🇷 France96.1%
🇺🇸 United States2.6%
🇩🇪 Germany1.3%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Synapse Medicine on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Synapse Medicine’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.